Expanding the Concept of Chemically Programmable Antibodies to RNA Aptamers: Chemically Programmed Biotherapeutics
- 19 July 2010
- journal article
- research article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 49 (34), 5934-5937
- https://doi.org/10.1002/anie.201001736
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Direct Observation of an Enamine Intermediate in Amine CatalysisJournal of the American Chemical Society, 2009
- Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate CancerJournal of the American Chemical Society, 2009
- An Antibody-Recruiting Small Molecule That Targets HIV gp120Journal of the American Chemical Society, 2009
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNature Biotechnology, 2009
- An efficient chemical approach to bispecific antibodies and antibodies of high valencyBioorganic & Medicinal Chemistry Letters, 2009
- Instant immunity through chemically programmable vaccination and covalent self-assemblyProceedings of the National Academy of Sciences of the United States of America, 2009
- β-Lactam-based approach for the chemical programming of aldolase antibody 38C2Bioorganic & Medicinal Chemistry Letters, 2009
- Molecular assembly for high-performance bivalent nucleic acid inhibitorProceedings of the National Academy of Sciences of the United States of America, 2008
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJCI Insight, 2008
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences of the United States of America, 2006